Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

The New York Times – Business:

Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.

This post first appeared in The New York Times – Business. Read the original article.